(Q44737179)

5 December 2017

title

Beyond cervical cancer: burden of other HPV-related cancers among men and women (English)

1 reference

5 December 2017

main subject

cervix uterine cancer

1 reference

Anil K Chaturvedi

1

1 reference

5 December 2017

language of work or name

1 reference

1 April 2010

1 reference

Journal of Adolescent Health

5 December 2017

published in

1 reference

5 December 2017

volume

46

1 reference

5 December 2017

issue

4 Suppl

1 reference

5 December 2017

page(s)

S20-6

1 reference

The economic burden of noncervical human papillomavirus disease in the United States

5 December 2017

cites work

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Human papillomavirus immortalization and transformation functions

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Burden of invasive squamous cell carcinoma of the penis in the United States, 1998-2003.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Understanding the burden of human papillomavirus-associated anal cancers in the US.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Burden of potentially human papillomavirus-associated cancers of the oropharynx and oral cavity in the US, 1998-2003.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Risk of human papillomavirus-associated cancers among persons with AIDS.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Clinical implications of human papillomavirus in head and neck cancers

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Human papillomavirus and cervical cancer

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Trends in the incidence of invasive and in situ vulvar carcinoma

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Prospects for cervical cancer prevention by human papillomavirus vaccination

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Incidence trends in primary malignant penile cancer.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

A comparison of cervical and vaginal human papillomavirus

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Age-specific prevalence, incidence, and duration of human papillomavirus infections in a cohort of 290 US men.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Human papillomavirus type 16 and TP53 mutation in oral cancer: matched analysis of the IARC multicenter study

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Is the incidence of invasive vulvar cancer increasing in the United States?

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Review of the economic and quality-of-life burden of cervical human papillomavirus disease

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

The epidemiology of anal human papillomavirus and related neoplasia

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Current topics in the epidemiology of oral cavity and oropharyngeal cancers

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Classification of papillomaviruses

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Safety and persistent immunogenicity of a quadrivalent human papillomavirus types 6, 11, 16, 18 L1 virus-like particle vaccine in preadolescents and adolescents: a randomized controlled trial.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Chapter 2: The burden of HPV-related cancers

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

High-Risk Human Papillomavirus Affects Prognosis in Patients With Surgically Treated Oropharyngeal Squamous Cell Carcinoma

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in healthy boys aged 10-18 years

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Incidence of in situ and invasive vulvar cancer in the US, 1998-2003.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Chapter 9: Role of mucosal human papillomavirus in nongenital cancers.

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

The global health burden of infection-associated cancers in the year 2002

1 reference

28 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1016/J.JADOHEALTH.2010.01.016

Identifiers

DOI

10.1016/J.JADOHEALTH.2010.01.016

1 reference

5 December 2017

1 reference